Psilocybin-assisted therapy for difficult-to-treat depression: underwhelming, but still vital?

feat

The EPISODE trial of psychedelic-assisted therapy for ‘treatment-resistant depression’ finds only modest effects, with a few clear responders, but lingering methodological questions.

[read the full story...]

MDMA-assisted therapy for depression: a promising but early first step

feat

A small proof-of-principle trial suggests MDMA-assisted therapy may be feasible and effective for depression, but open-label design and a highly pre-treated sample urge caution.

[read the full story...]

Stopping antidepressants safely: network meta-analysis compares deprescribing strategies

elsa-olofsson-QwFyqPKyyY0-unsplash

This network meta-analysis of 76 trials found that slow tapering (over 4 weeks) combined with psychological support was most effective for preventing relapse when stopping antidepressants. Abrupt discontinuation and fast tapering substantially increased relapse risk and should be avoided.

[read the full story...]

Recovery, relapse, and genetic risk: what 10,000 Danes taught us about eating disorder trajectories

Abstract Wavy Fluid Pattern – Psychedelic Optical Illusion Background Vector.

How often do people with eating disorders switch diagnoses, recover, or relapse? This large Danish study follows more than 10,000 people over nearly a decade, uncovering patterns of remission and genetic vulnerability that could help shape more personalised care.

[read the full story...]

Adolescent versus adult depression: Is risk of recurrence the same?

vitaly-gariev-_Am5E9vcsu8-unsplash

Is teenage depression more likely to come back later in life? A new population study challenges assumptions and finds similar recurrence risks in both adolescents and adults.

[read the full story...]

Can proteomics improve our prediction of depression remission?

alina-grubnyak-ZiQkhI7417A-unsplash

Jonas Hagenberg discusses new insights into the possible use of proteomics (the large-scale study of proteins) for improving our prediction of depression remission.

[read the full story...]

Sitting in the waiting room: what happens when anxiety disorders are left untreated?

levi-meir-clancy-jdIT3puximI-unsplash

In her debut blog, Beth Hindhaugh summarises a systematic review and meta-analysis of 173 studies examining the untreated course of anxiety disorders, which finds that for some people, anxiety disorders can improve without treatment.

[read the full story...]

The global burden of disease from mental disorders remains high

Business,Challenge,And,Burden,Vector,Concept.,Symbol,Of,Problems,,Issues,

Alejandro Arguelles Bullon summarises the latest Global Burden of Disease study (2019) looking at the prevalence, incidence and impact that mental disorders have on our lives, which shows no reduction in the burden over the last 30 years.

[read the full story...]

ADHD remission: why do some children ‘outgrow’ ADHD whilst others don’t?

shutterstock_1404629135

A group of UCL Mental Health Masters students summarise a recent literature review that explores the potential pathways to ADHD remission.

[read the full story...]

Anorexia nervosa: relapse, remission and recovery

5748973131_6bcc08ba31_b

Sarah McDonald asks: What happens after treatment? She summarises a recent systematic review of relapse, remission, and recovery in anorexia nervosa.

[read the full story...]